Massmedica Temettü

Temettü kriter kontrolleri 0/6

Massmedica does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

-2.3%

Geri Alım Getirisi

Toplam Hissedar Getirisi-2.3%
Gelecekteki Temettü Verimin/a
Temettü Büyümesin/a
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettün/a
Ödeme oranın/a

Son temettü güncellemeleri

Recent updates

Massmedica S.A.'s (WSE:MSM) 26% Share Price Surge Not Quite Adding Up

Oct 12
Massmedica S.A.'s (WSE:MSM) 26% Share Price Surge Not Quite Adding Up

Massmedica S.A.'s (WSE:MSM) Shares Climb 31% But Its Business Is Yet to Catch Up

Aug 07
Massmedica S.A.'s (WSE:MSM) Shares Climb 31% But Its Business Is Yet to Catch Up

There's Reason For Concern Over Massmedica S.A.'s (WSE:MSM) Massive 44% Price Jump

Jun 20
There's Reason For Concern Over Massmedica S.A.'s (WSE:MSM) Massive 44% Price Jump

Optimistic Investors Push Massmedica S.A. (WSE:MSM) Shares Up 41% But Growth Is Lacking

Mar 07
Optimistic Investors Push Massmedica S.A. (WSE:MSM) Shares Up 41% But Growth Is Lacking

Calculating The Intrinsic Value Of Massmedica S.A. (WSE:MSM)

Jan 05
Calculating The Intrinsic Value Of Massmedica S.A. (WSE:MSM)

I Ran A Stock Scan For Earnings Growth And Massmedica (WSE:MSM) Passed With Ease

Sep 14
I Ran A Stock Scan For Earnings Growth And Massmedica (WSE:MSM) Passed With Ease

Massmedica S.A.'s (WSE:MSM) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Dec 15
Massmedica S.A.'s (WSE:MSM) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if MSM's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if MSM's dividend payments have been increasing.


Piyasaya Karşı Temettü Getirisi

Massmedica Piyasaya Karşı Temettü Getirisi
MSM temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (MSM)n/a
Pazarın Alt %25'i (PL)2.8%
Pazarın En İyi %25'i (PL)8.0%
Sektör Ortalaması (Healthcare)2.3%
Analist tahmini (MSM) (3 yıla kadar)n/a

Önemli Temettü: Unable to evaluate MSM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate MSM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate MSM's payout ratio to determine if its dividend payments are covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as MSM has not reported any payouts.


Güçlü temettü ödeyen şirketleri keşfedin